These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15492790)
1. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors. Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790 [TBL] [Abstract][Full Text] [Related]
2. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin. Hughes JH; Robinson RA Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663 [TBL] [Abstract][Full Text] [Related]
4. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma. Matsumoto M; Furihata M; Kurabayashi A; Sasaguri S; Araki K; Hayashi H; Ohtsuki Y Oncology; 2004; 67(2):143-50. PubMed ID: 15539919 [TBL] [Abstract][Full Text] [Related]
6. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
7. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Hida Y; Kubo Y; Murao K; Arase S Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656 [TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120 [TBL] [Abstract][Full Text] [Related]
9. Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract. Furihata M; Kurabayashl A; Matsumoto M; Sonobe H; Ohtsuki Y; Terao N; Kuwahara M; Shuin T J Pathol; 2002 May; 197(1):82-8. PubMed ID: 12081208 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin. Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma. Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma. Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788 [No Abstract] [Full Text] [Related]
13. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas. Wrone DA; Yoo S; Chipps LK; Moy RL Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526 [TBL] [Abstract][Full Text] [Related]
14. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma. Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287 [TBL] [Abstract][Full Text] [Related]
16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia. Makino T; Tatebe S; Goto A; Mihara M; Ito H J Cutan Pathol; 1998 Mar; 25(3):136-42. PubMed ID: 9550311 [TBL] [Abstract][Full Text] [Related]
18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Sakiz D; Turkmenoglu TT; Kabukcuoglu F Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human epidermal tumors. Liu ZL; Li Y; Kong QY; Zhan C; Wang Q; Chen XY; Sun Y; Wen S; Tu CX; Liu J; Li H J Dermatol Sci; 2008 Nov; 52(2):133-6. PubMed ID: 18703315 [No Abstract] [Full Text] [Related]
20. Overexpression of p53 protein in basal cell carcinomas of human skin. Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]